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Background: Respirable crystalline silica (silicon dioxide; SiO2, quartz) particles are known to induce chronic
inflammation and lung disease upon long-term inhalation, whereas non-crystalline (amorphous) SiO2 particles in the
submicrometre range are regarded as less harmful. Several reports have demonstrated that crystalline, but also non-
crystalline silica particles induce IL-1β release from macrophages via the NALP3-inflammasome complex (caspase-1,
ASC and NALP3) in the presence of lipopolysaccharide (LPS) from bacteria. Our aim was to study the potential of
different non-crystalline SiO2 particles from the nano- to submicro-sized range to activate IL-1β responses in LPS-
primed RAW264.7 macrophages and primary rat lung macrophages. The role of the NALP3-inflammasome and up-
stream mechanisms was further explored in RAW264.7 cells.
Results: In the present study, we have shown that 6 h exposure to non-crystalline SiO2 particles in nano- (SiNPs,
5–20 nm, 50 nm) and submicro-sizes induced strong IL-1β responses in LPS-primed mouse macrophages
(RAW264.7) and primary rat lung macrophages. The primary lung macrophages were more sensitive to Si-exposure
than the RAW-macrophages, and responded more strongly. In the lung macrophages, crystalline silica (MinUsil 5)
induced IL-1β release more potently than the non-crystalline Si50 and Si500, when adjusted to surface area. This
difference was much less pronounced versus fumed SiNPs. The caspase-1 inhibitor zYVAD and RNA silencing of the
NALP3 receptor reduced the particle-induced IL-1β release in the RAW264.7 macrophages. Furthermore, inhibitors
of phagocytosis, endosomal acidification, and cathepsin B activity reduced the IL-1β responses to the different
particles to a similar extent.
Conclusions: In conclusion, non-crystalline silica particles in the nano- and submicro-size ranges seemed to induce
IL-1β release from LPS-primed RAW264.7 macrophages via similar mechanisms as crystalline silica, involving particle
uptake, phagosomal leakage and activation of the NALP3 inflammasome. Notably, rat primary lung macrophages
were more sensitive with respect to silica-induced IL-1β release. The differential response patterns obtained suggest
that silica-induced IL-1β responses not only depend on the particle surface area, but on factors and/or mechanisms
such as particle reactivity or particle uptake. These findings may suggest that bacterial infection via LPS may
augment acute inflammatory effects of non-crystalline as well as crystalline silica particles.
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The general population is exposed to crystalline silica (sili-
con dioxide; SiO2) particles, abundant in nature as quartz
and other minerals. Airborne quartz particles are also
encountered in numerous occupations, including mining
and construction work. Chronic exposure to respirable
quartz particles is associated with ongoing cell injury, fi-
brosis (silicosis) and lung cancer [1-3]. Non-crystalline sil-
ica (amorphous) particles are generally regarded to be
safer, with no or less chronic effects [4-6]. Thus, non-
crystalline silica particles are now increasingly used for
various applications including construction work, medical
diagnosis, cancer therapy and drug delivery, and are added
to cosmetics and food. However, the increasing use of vari-
ous forms of non-crystalline silica particles, and in particu-
lar the nano-sized, requires more thorough examination of
their possible health effects.
Scavenging of quartz particles by resident macrophages
leads to direct release of inflammatory cytokines, which
seems to be crucial in the development of silicosis [1,7].
Notably, a persistent overproduction of the pro-inflamma-
tory cytokine IL-1β has been linked to silicosis [8]. Reduc-
tion of experimentally-induced silicosis has been observed
upon treatment with IL-1 receptor antagonists as well as
in IL-1β knockout mice, confirming IL-1β as a key inflam-
matory regulator [9,10]. Furthermore, other studies have
shown that crystalline silica particles (quartz) can trigger
the release of IL-1β from macrophages [11].
Extensive research in recent years has revealed that the
IL-1β response is regulated by two separate mechanisms.
First activation of toll-like receptors (TLRs) is leading to
increased levels of pro-IL-1β. The next step may involve
the intracellular pattern recognition receptor NALP3,
resulting in maturation and release of IL-1β. TLRs are
often activated by ligation of pathogen-associated mo-
lecular pattern (PAMP) and danger associated molecular
pattern (DAMP) molecules. This triggers a cellular signal-
ing cascade, which increases transcription of the pro-IL-1β
gene via the transcription factor NFκ-B. The NALP3 is a
multi-ligand sensing protein that recognizes a variety of
host-derived danger signals, including DAMPs. Upon
ligation, the NALP3 binds the adaptor protein ASC and
pro-caspase-1 in the inflammasome multi-protein com-
plex. The inflammasome assembly will spontaneously
activate caspase-1, which cleaves pro-IL-1β and causes a
release of IL-1β [12-14]. Partly based on the successful
treatment with IL-1β receptor antagonists, the NALP3
inflammasome is suggested to have an important patho-
genic role in several inflammatory diseases including
gout, type 2 diabetes and cardiovascular disease [15-21].
Several studies have focused on the crystalline struc-
ture of particles as a crucial factor for triggering the
inflammasome response. Accordingly, biologically relevantcrystals, such as monosodium urate (MSU), have been
suggested to be important for the NALP3/IL-1β-driven
inflammation in gout disease [22,23]. Cholesterol crystals
seem to contribute to atherogenesis via inflammasome
activation [24]. It has also been reported that the crys-
talline silica particles (quartz) activate the NALP3 inflam-
masome, possibly via particle uptake, rupture of lysosomal
membranes and subsequent release of cathepsin B [14,25].
The quartz-induced NALP3 activation and subsequent
IL-1β release has recently been more directly linked to
the development of silicosis upon chronic exposure [26].
A critical question is to what extent the inflammasome
activation by silica particles requires the crystalline struc-
ture, or whether non-crystalline (amorphous) silica parti-
cles of different sizes also may induce inflammasome
responses. Several studies have reported that non-
crystalline silica particles may induce inflammasome
activation, but the results differ depending on the par-
ticle size and the cell types examined [27-29]. In the
present in vitro study we have investigated the poten-
tial of different non-crystalline silica particles to induce
IL-1β release from LPS-primed RAW264.7 macrophage
as well as primary rat lung macrophages. The macro-
phages were exposed to such silica particles in the nano-
and submicro-ranges (50 and 500 nm nominal size) and
of two types of poly-disperse non-crystalline silica par-
ticles of industrial origin (fumed silica, fused silica). To
compare with crystalline silica micrometer-sized quartz
(MinUsil 5) was included. The mechanisms behind the
IL-1β release in the RAW264.7 macrophages were inves-
tigated, including the role of particle phagocytosis, lyso-
somal membrane stability, release of lysosomal proteases
and NALP3 activation.Results
Characterization of the particles
Non-crystalline silica particles in the nanometer- and
submicro-sizes, expected to be both mono-disperse and
poly-disperse (see Materials and Methods), were charac-
terized with regard to morphology size (TEM, DLS),
BET surface area and surface charge (ζ-potentials). In
Figure 1 TEM micrographs are shown and a typical ag-
gregate of fumed silica is presented in Figure 1A. The
primary particles are approximately 20 nm in size; and
they are sintered together thereby forming an open por-
ous network. In Figure 1B the angular morphology of
cleaved fused silica particles is clearly illustrated. These
micrographs represent the particles before wet sedimen-
tation. Sinterbridges, as visible in the TEM micrographs
of the fused silica particles, are artefacts of the wet sam-
ple preparation. The quasi-spherical, mono-disperse Si50
particles and the perfectly spherical, mono-disperse
Figure 1 Morphology of various non-crystalline silica particles. TEM-micrographs of the particles; using Philips CM30; FEG, 300 kV, are
presented. A) Fumed silica (Aerosil 200, scale bar: 50 nm) B) Fused silica (Suprasil, scale bar 200 nm) before wet sedimentation C) 50 nm
monodisperse silica (Si50, scale bar: 100 nm) D) 500 nm monodisperse silica (Si500, scale bar: 1 μm).
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spectively. In contrast to fumed silica, the primary spher-
ical particles form loose agglomerates due to van-der-
Waals forces.
Table 1 shows the nominal sizes given for the particles
as well as sizes measured in our TEM-instrument. In
addition the surface areas by BET-analysis and the ζ-
potentials in water are included. TEM investigations
revealed that the particle size of the Si50 sample was
slightly larger (64 nm) than its nominal size. The particle
size of the Si500 sample was 370 nm. Our own measure-
ments are also presented for the fumed and fused silica
particles. The BET surface area of fumed silica particles
was found to be the largest with 1880 cm2/mg. The sur-
face area of fused silica was nearly 1/100 part of this.
The surface area of Si50 was approximately a third of the
fumed silica particles, and 7-fold higher than their Si500
counterpart. Notably, both the presented values for the
TEM measurements and the surface area for the fused
silica particles are before wet sedimentation. With re-
spect to the ζ-potentials in water, the particles showedTable 1 Characteristics of non-crystalline silica particles
Silica particles TEM (own measurements)
Silica (50 nm, Si50) 64 ± 7.7 nm
Silica (500 nm, Si500) 369 ±19.7 nm
Fumed silica (Aerosil) ~20 nm
Fused silica (Suprasil) *500 nm −10 μm
The characteristics (TEM; surface area, and ζ-potentials) of two different mono-dispe
two different poly-disperse amorphous silica particles are presented. The TEM, ζ-pot
Material and Methods. * The TEM and the surface area of the fused particles were m
ζ-potential was measured for the fused particles after wet sedimentation.relatively similar values, ranging from −23.9 to −37.2,
with the fumed particles as least negative and Si500 as
most negative.
Table 2 summarizes the hydrodynamic size by DLS of
all the particles dispersed in sterile water with and with-
out sonication and addition of BSA and PBS (stock solu-
tion), and after dispersion of the sonicated particles in
culture media plus serum, both instantly and after 2 h.
In the Additional file 1 the DLS distribution curves are
given for Si50 and Si500 (Additional file 1: Figure S1)
and fumed and fused silica particles (Additional file 1:
Figure S2). The DLS-size of the Si50 in water was ap-
proximately of the same size as measured by TEM. After
dispersion in a stock solution the DLS-sizes were moder-
ately larger, and these sizes were kept after dispersion in
culture medium (DMEM+10% FCS), both instantly and
after 2 h. For the Si500, the DLS-size in water was some-
what larger than the measured TEM-size, and was
slightly increased in the stock solution and in culture
media. For the fumed silica particles a more complex





rse non-crystalline (amorphous) silica particles with different nominal size, and
entials (in water), and the particle surface areas were measured as described in
easured before wet sedimentation and include larger particles. **The
Table 2 Size distribution of different non-crystalline silica particles as measured by DLS-measurements
Silica particles In water In stock-solution(+/-) In medium In medium after 2h
Fraction 1 Fraction 2 Fraction 1 Fraction 2 Fraction 1 Fraction 2 Fraction 1 Fraction 2
Silica (50 nm,Si50) 68.5 91 91 91
Silica 500 (500 nm, Si500) 458 531 531 531
Fumed silica (Aerosil) 122 458 220 1700 295 255
Fused silica (Suprasil) 342 396 342 5560 342 5560
The table presents the sizes for the intensity of the non-crystalline silica particle peaks, as shown in addition file 1, Figure 1 and 2.
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at 122 nm and one peak at 458 nm (mean intensities),
which is due to the aggregation and agglomeration charac-
teristics, respectively. Upon sonication and BSA/PBS sup-
plementation a major peak was observed with a size of
220 nm. Upon dispersion in culture medium, the peak
shifted slightly to 295 at 0 h and 255 at 2 h. The fused
silica particles, using the smallest fraction after wet
sedimentation, displayed a mono-disperse pattern in sterile
water with a sharp peak at 342 nm, and somewhat larger
(396 nm) after sonication and BSA/PBS supplementation.
For all the particles, peaks in the lower size range (7–
30 nm) might be due to proteins or other artefacts and the
small peaks in the large size area (approximately 5000 nm)
might represent agglomeration of particles.
Non-crystalline silica particles induced IL-1β release from
LPS-primed RAW264.7 cells
RAW264.7 macrophage cultures were primed with LPS
(25 ng/ml, 3 h) before exposure to different silica parti-
cles for 6 h (Figure 2). Although significant IL-1β
responses were induced by all particles, with exception
of fused particles, large variations in the IL-1β responses
after exposure to particles could be seen, as illustrated in
Figure 2A, showing the effect of a high concentration
(200 μg/ml) of Si50; Si500, fumed and fused silica, and
MinUsil 5 in LPS-primed cells. However, the relative par-
ticle responses within each experiment were similar.
Thus, in order to remove this unwanted inter-experimental
variation, typical experiments are presented. Figure 2B
shows the IL-1β responses to Si50 and MinUsil 5 with and
without LPS pre-treatment. Without LPS negligible
responses were observed, whereas the responses were
strikingly augmented in LPS-primed cells. The response to
Si50 was at least of the same magnitude as the response to
the same concentration of MinUsil 5. In time-response
experiments with LPS-primed cells, using Si50 (200 μg/ml)
(Figure 2C), no or only a slight IL-1β response was
detected at 2 h, whereas at 5 h a marked response was
observed. The response lasted for at least 10 h. In
Figure 2D, the concentration-response relationships for
Si50-, Si500-, fumed- and fused silica particles with respect
to IL-1β responses in LPS-primed cells, as related to mass,
are presented. The nano-sized SiNPs showed a leftwardshift of the concentration-response curve compared to the
larger non-crystalline silica particles. The Si50 induced an
effect at 50 μg/ml or higher, whereas Si500 elicited an ef-
fect at 100 μg/ml or higher. The responses to Si50 and
Si500 increased progressively up to 500 μg/ml. Also the
fumed and fused particles both induced IL-1β release in a
concentration-dependent manner. The response to the
fumed particles was most marked, with a distinct leftward
shift compared to the other particles and a distinct re-
sponse at a concentration as low as 5 μg/ml. The fused
silica particles showed a response from 50 μg/ml. In
Figure 2E, the IL-1β responses of Si50, Si500 and fumed
silica in relation to particle surface area were compared.
Si500 seemed to be more potent than Si50, as Si500
reached a response of approximately 90 pg/ml at a sur-
face area of 40 cm2/well, and the Si50 reached the same
response at around 300 cm2/well. The fumed silica par-
ticles were more potent than the Si50, with an approxi-
mate 3-fold leftward shift. For the fused silica particles
the relationship between IL-1β response and surface
area is not presented, as the particle surface area of these
particles was only measured before wet sedimentation.
The cytotoxicity, as assessed by LDH release, was also
examined for all these particles. In general, at 100–
200 μg/ml the LDH-increase after 6 h exposure was less
than 2–2.5 fold with the fumed and fused silica as most
and least potent, respectively (data not shown), showing
that the measured IL-1β release not was due to unspe-
cific toxic effects.
IL-1β release from primary lung rat macrophages after
exposure to silica particles
The effects of the different particles on IL-1β release
were also examined in primary rat lung macrophages.
All the particles induced significant IL-1β responses. In
Figure 3A the variability of the IL-1β responses to
200 μg/ml Si50 and Si500, 50 μg/ml fumed silica, fused
silica and MinUsil 5 in LPS-primed cells, is illustrated. In
Figure 3B the responses to Si50 and MinUsil 5 with and
without LPS-priming were compared, showing virtually
no responses without LPS and large responses with LPS.
In Figure 3C and D the concentration-response relation-
ships to all the particles were compared, related to
mass. Notably, the sensitivity of primary alveolar rat
Figure 2 IL-1β release induced by non-crystalline silica particles in mouse RAW264.7 macrophages. The cells were primed for 3 h with
and without LPS (25 ng/ml) and subsequent exposed to different non-crystalline silica particles and MinUsil 5 (MinU) for 6 h A) Effects of Si50,
Si500, fumed and fused silicas, besides MinU (200 μg/ml) in LPS-primed cells B) Effects with or without LPS and subsequent exposure to Si50
(200 μg/ml) and MinU (200 μg/ml) C) Time-dependent effect (2–10 h) by Si50 (200 μg/ml) on IL-1β release in LPS-primed cells D) Concentration
(mass/ml)-response relationships for Si50, Si500, fumed silica (fumed Si) and fused silica (fused Si) on IL-1β release in LPS-primed cells E) IL-1β
responses in relation to particle surface areas in LPS-primed cells. The results for Si50, Si500 and fumed silica particles are presented for surface
areas. Fused silica particles after wet sedimentation were used. The IL-1β levels were determined by ELISA. In A) the variability of the results are
presented by the mean± SD, including data from 3 to 5 experiments. * = p < 0.05 versus control, using Kruskal-Wallis test with Dunn’s Multiple
Comparison test as a post-test. In B-E representative experiments are given, all performed in duplicates as indicated.
Sandberg et al. Particle and Fibre Toxicology 2012, 9:32 Page 5 of 13
http://www.particleandfibretoxicology.com/content/9/1/32macrophages to all these silica particles was markedly
greater compared to RAW264.7 macrophages. Further-
more, the magnitude of IL-1β release (fold-increase) was
much greater in the primary cells than in the RAW264.7
macrophages. On a mass basis the nano-sized fumed sil-
ica particles were the most potent of the non-crystalline
silica particles, with effects as low as from 1–5 μg/ml
(equivalent to approximately 12.5-25 cm2/well). The
submicro-sized fused silica particles also induced an IL-
1β response at rather low concentration (from 5–50 μg/
ml), but was markedly less potent than the fumed silica
particles. The mono-disperse Si500 showed less potency
than Si50 on a mass basis. MinUsil 5 induced marked
IL-1β responses as low as 10 μg/ml. When comparing
the IL-1β response in relation to particle surface area the
order of potency was: MinUsil 5 > fumed silica > Si500 >
Si50 (Figure 3E). For the MinUsil 5 (delivered by the
same producer) the surface area obtained by Warheit
et al. 2007 [30], (5,1 m2/g) was used in the calculation.The cytotoxicity, as assessed by LDH-release after 6 h
exposure, was also examined. At 50–100 μg/ml fumed
silica showed a 2-fold increase, whereas Si50 showed no
increase at these concentrations. In comparison, the IL-
1β release in the parallel experiments was many-fold lar-
ger (data not shown).
Particle-induced IL-1β release via caspase-1 and NALP3 in
RAW264.7 -macrophages
The roles of pro-IL-1β changes and caspase-1 and
NALP3 in induction of IL-1β release by non-crystalline
silica particles in RAW264.7 macrophages were exam-
ined. Figure 4A shows that MinUsil 5-induced IL-1β re-
lease was almost completely inhibited by the specific
caspase-1 inhibitor, zYVAD (10 μM). Similarly, zYVAD
completely inhibited the IL-1β release induced by the
fumed silica particles, Si50 and fused silica particles
(Figure 4B). The basal IL-1β levels were not affected by
zYVAD. Figure 4C shows by Western blotting that LPS
Figure 3 IL-1β release induced by non-crystalline and crystalline silica particles in primary rat lung macrophages. The cells were primed
for 3 h with and without LPS (25 ng/ml) and subsequent exposed to different non-crystalline silica particles and MinUsil 5 (MinU) for 6 h. A)
Effects of the 200 μg/ml Si50 and Si500, and 50 μg/ml fumed silica (fumed Si), fused silica (fused Si) and MinU in LPS-primed cells B) Effects with
or without LPS and subsequent exposure to Si50 (200 μg/ml) and MinU (50 μg/ml) C) Concentration (mass/ml)-response relationships for Si50
versus Si500 on IL-1β release in LPS-primed cells D) Concentration (mass/ml)-response relationships for fumed- and fused silica and MinU on
IL-1β release in LPS-primed cells. Fused silica particles after wet sedimentation were used. E) IL-1β responses in relation to particle surface areas in
LPS-primed cells. In E the results for Si50, Si500 and fumed silica particles, besides MinUsil 5, are presented. The IL-1β levels were determined by
ELISA. In A) the variability of the results is presented by the mean± SD, including data from 5 experiments. * = p< 0.05 versus control, using
Kruskal-Wallis test with Dunn’s Multiple Comparison test as a post-test. In B- E representative experiments are given, all performed in duplicates as
indicated.
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and that exposure to 200 μg/ml Si50 reduced the levels.
To assess the involvement of NALP3, a siRNA gene si-
lencing probe against the NALP3 receptor was used. As
shown in Figure 5A, the NALP3 siRNA knockdown sup-
pressed the IL-1β response to MinUsil 5 and Si50 in
RAW264.7 macrophages. A similar suppressive effect
was not found for the non-specific negative control
siRNA. RT-qPCR was used to confirm approximately
85% NALP3 gene knock-down efficiency relative to cells
transfected with the negative control probe (Figure 5B).
Mechanisms in inflammasome activation by non-crystalline
silica in RAW264.7 macrophages
To examine the role of particle uptake and endosome
membrane destabilization after phagocytosis, with subse-
quent leakage of the activated lysosome protease cathe-
psin B into cytosol, we used a panel of inhibitors [14].
The inhibitors cytochalasin D (inhibitor of actin assem-
bly and phagocytosis), bafilomycin (inhibitor of vacuolar
H+−ATPase and acidification of endosomes) andCa074Me (inhibitor of cathepsin B) were added before
exposure to the silica particles. The results showed that
all inhibitors markedly reduced IL-1β release from
RAW264.7 macrophages upon exposure to 200 μg/ml
MinUsil 5, Si50, fumed silica and fused silica, although
significance was not reached in all instances (Figure 6).
Discussion
Crystalline structures such as quartz particles have previ-
ously been reported to activate the NALP3 inflamma-
some [14,25], a mechanism suspected to play an
important role in the development of diseases such as
silicosis [26]. In the present study we show how different
non-crystalline (amorphous) silica particles from nano-
to submicro-sizes are potent inducers of inflammasome
activation, thus acting via the NALP3 assembly, leading
to a caspase-1-dependent pro-IL-1β maturation and IL-
1β release. When related to surface area the order of po-
tency for IL-1β release in the lung macrophages was
MinUsil 5 > fumed, silica > Si500 > Si50. The non-
crystalline and crystalline silica particles are suggested to
Figure 4 Effect of caspase-1 inhibition on IL-1 β release in RAW
264.7 macrophages. The cells were primed for 3 h by LPS
(25 ng/ml) and subsequently exposed to silica particles after 6 h. The
caspase-1 inhibitor zYVAD (10 μM) was added 1 h prior to exposure
to MinUsil 5 (MinU, 200 μg/ml) (A) and 200 μg/ml Si50, fumed silica
and fused silica (B), and the IL-1β responses were determined by
ELISA. For fused silica, particles after wet sedimentation were used. In
A, B the IL-1β levels represent 6 experiments, and are presented as
mean± SD of fold change. * = p< 0.05 significant different from
particle-stimulated cells without zYVAD, using Kruskal-Wallis test with
Dunn’s Multiple Comparison test as a post-test. C) Levels of pro-IL-
1β. The cells were pre-treated with and without LPS for 3 h, and
exposed to with Si50 (200 μg/ml) for 6 h and assessed for pro-IL-β
levels by Western analysis. A representative Western blot is shown. In
the lower part the band intensity of this experiment is shown.
Figure 5 Non-crystalline and crystalline silica particles induce
IL-1β release in RAW264.7 macrophages via the NALP3
inflammasome. A) The cells were transfected with siRNA against
NALP3 as well a negative control for 48 h, then primed for 3 h by
LPS (25 ng/ml before exposure to Si50 (200 μg/ml) or MinUSil 5
(200 μg/ml). The IL-1β levels were determined by ELISA. B) The
NALP3 mRNA levels after transfection by siRNA against NALP3 and
by a negative control siRNA. The NALP3 mRNA levels were adjusted
against the respective actin-mRNA levels. Data presented are
representative of two experiments performed in duplicates.
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take and phagosomal stabilization seem to affect the
inflammasome activation by these different particles in a
similar manner, as demonstrated in RAW-macrophages.
Our results support and elaborate previous findings
suggesting that a crystalline structure is not required for
silica particles to activate the inflammasome. Non-
crystalline silica particles have been found to induce a
boost of IL-1β release in LPS-primed murine macro-
phages [29], TPA-primed THP-1 monocytic cells [27]
murine dendritic cells [28] and keratinocytes [29]. In the
dendritic cells the existence of an inflammasome mech-
anism was demonstrated by using cells from NALP3-
and caspase-1-deficient mice [28]. For the THP-1 cells
the involvement of an inflammasome mechanism was
supported by inhibition of IL-1β release by zYVAD, an
inhibitor of caspase-1 [27]. In the present study the
inflammasome mechanism induced by different non-
crystalline silica particles was demonstrated both by use
of the caspase-1 inhibitor zYVAD and by siRNA against
the NALP3 in RAW274.7 macrophages.
Some studies also point to other nanoparticles that
may induce NALP3 inflammasome responses, such as
TiO2-particles, amino-functionalized polystyrene particles
and carbon black particles in macrophages [29,31-33].
In contrast, nanoparticles, like diesel exhaust particles,
ZnO-NPs and carboxyl-functionalized polystyrene NPs
[25,29,31], do not seem to show such responses. A
remaining question is which nanoparticle characteristics
and types of functionalisation are required to elicit
NALP3 inflammasome responses.
In previous studies the IL-1β responses to non-
crystalline particles varied with size, and also with cell
type used. Morishige and coworkers [27] observed that
the non-crystalline silica particles of 1000 nm size
induced an IL-1β release in TPA-primed THP-1 cells,
whereas the 30 to 300 nm counterparts were without ef-
fect. In murine macrophages approximate similar IL-1β
levels were reported in the presence of a high
concentration of non-crystalline silica particles of nano
(15 nm)- and micrometer (1.5 μm)-size, whereas only
the nano-sized particles induced IL-1β release in human
keratinocytes [29]. Winter and coworkers [28], showed
that 14 nm silica nanoparticles induced a marked IL-1β
release in LPS-primed murine dendritic cells. In the
RAW264.7 macrophages and rat primary lung macro-
phages we observed that both silica particles from the
nano-size (Si50, fumed silica) and submicro-size (Si500
and fused silica), besides the crystalline MinUSil 5,
induced marked IL-1β responses.
The potential to induce inflammatory responses at low
concentrations is a critical question. In dendritic cells,
the potency of the non-crystalline silica nanoparticles
(14 nm) on a mass basis was approximately similar to
Figure 6 Involvement of uptake and lysosomes in inflammasome activation by non-crystalline and crystalline silica in RAW264.7
macrophages. The cells were primed for 3 h by LPS (25 ng/ml), and then pre-treated for 30 min with the indicated concentrations of
cytochalasin D, bafilomycin or Ca074Me before exposure to different silica particles (200 μg/ml) for 6 h. A) MinUsil 5 (MinU); B) Si50 C) Fumed
silica particles D) Fused silica particles. The IL-1β levels were determined by ELISA. Data represent the mean± SD of 6 experiments and are
presented as fold change. * = p< 0.05; significant different from particle-stimulated cells without inhibitors (light grey bars); using Kruskal-Wallis
test with Dunn’s Multiple Comparison test as a post-test.
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was less potent than quartz (MinUsil 5) on a mass basis,
when examined in primary lung macrophages. The
fumed silica with the smallest size (5–20 nm), but also a
different composition, was however on mass basis the
most potent of all the particles examined, giving IL-1β
responses from rather low concentrations (1–5 μg/ml).
This supports the potential relevance of these findings,
suggesting that additional toxic studies on these particles
could be of interest. In other studies the concentrations
of non-crystalline silica particles used to induce IL-1β re-
lease were mostly in a higher range [27,28], than those
used in the present study.
In general, in many previous studies using cell cultures,
nano-sized particles seemed more potent compared to
larger particles of the same composition, when presented
on a mass basis. However, these differences tend to dis-
appear when relating the responses to particle surface
area both upon in vitro and in vivo [34,35] exposure. In
accordance with this, we find that when assessing the IL-
6 and IL-8 response to Si50 and Si500 in BEAS-2 B-cells,
the particle surface area seems to be the critical deter-
minant (unpublished results). However, with regard to
the IL-1β responses in primary rat lung macrophages and
in particular in mouse RAW-macrophages, the Si500 sil-
ica particles seemed markedly more potent than Si50 of
the same composition, when presenting the responses in
relation to particle surface area. These somewhat surpris-
ing finding could be due to a different role of particle up-
take for various cytokine responses. Our previous study
indicated that the increased IL-6 and IL-8 release follow-
ing Si50 in BEAS-2 cells seemed to occur independently
of particle uptake [36]. In contrast, the IL-1β response inRAW264.7 macrophages, shown in the present study,
seemed to be dependent on uptake of the silica particles
(see below). Notably, it is known that particle uptake via
phagocytosis is less effective with nano-sized particles
than with larger particles around 0.5 μm [37]. Thus, the
present finding with Si500 as more effective inducers of
IL-1β than Si50 in RAW264.7 macrophages and primary
rat lung macrophages at comparable particle surface
areas could be related to more effective particle uptake,
although it cannot be excluded that other explanations
may be involved. Previous inhibitor studies have shown
that uptake of micro-sized crystalline silica particles in
alveolar macrophages occurring via actin-dependent
phagocytosis [38] is required for eliciting inflamma-
some response [14]. In our study, uptake of all the
non-crystalline silica particles of various sizes also
seemed to be mediated via a mechanism that was
actin-dependent, as cytochalasin D inhibited the IL-1β
responses. However, both phagocytosis and macropino-
cytosis are actin-based pathways [37]. For nano- and
submicro-sized particles, that are relevant for the present
study, it has been reported that the extent of uptake in
macrophages differ, with several mechanisms operating
for particles of different sizes and functionalisation
[37,39-43]. Furthermore, the mechanisms of uptake are
dependent on the differentiation state of the macro-
phages and the proteins that the nanoparticles encounter
in culture media. Thus, in primary macrophages opso-
nised by serum proteins nanoparticles (polystyrene) were
taken up by phagocytosis, whereas other mechanisms
operated in monocytic THP1 cells with and without
differentiation with TPA [42]. The similar patterns of
responses to cytochalasin D and the other inhibitors to
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were surprising, as it points to a common mechanism
operating over the whole particle size range. One possible
explanation could be that the secretion of IL-1β from the
cells was actin-dependent. Previous studies in bone mar-
row dendritic cells have however shown that cytochalasin
D does not interfere with the secretion process of IL-1β
[14]. More conceivably, the agglomeration state of the
particles could be of importance for the similar
responses of nano-and submicro-sized silica particles to
cytochalasin D. Thus, the macrophages might sense all
the different particles as sub-micrometer agglomerates,
pointing to phagocytosis as a common mechanism for
particle uptake. This was discussed by Winter et al. [28],
but the agglomeration state of the non-crystalline parti-
cles was not assessed. In the present study the hydro-
dynamic size of all the particles in the culture medium
with serum, was from 90 nm and larger. The optimal par-
ticle size for phagocytosis has been reported to be relative
large, 250 nm to 3 μm, whereas nanoparticles less than
250 nm were less effectively phagocytosised [37,41].
Further studies are, however, required to approach the
importance of the agglomeration process for the inflam-
masome activation.
With further respect to mechanisms, our findings sug-
gest that the IL-1β responses induced by the non-
crystalline particles in the RAW264.7 macrophages involve
activation of the vacuolar H+-ATPase, and induction of
cathepsin B release, subsequently leading to phagosomal
destabilization, as previously reported for quartz particles
[14]. In a recent study, Morishige [27] found that the IL-
1β response induced by 1000 nm non-crystalline silica
particles was markedly reduced by inhibitors of these pro-
cesses. Here, we report that the IL-1β responses by all the
different silica particles were nearly abolished upon pre-
treating the RAW264.7 macrophages with relevant inhi-
bitors such as bafilomycin A1 and CA-074-Me. Thus, our
findings corroborate that non-crystalline silica particles of
different sizes and composition and crystalline silica par-
ticles, act via similar mechanisms. Previous studies in
endothelial cells have shown that non-crystalline silica
particles may induce cytotoxic responses, with the particles
in nano-size as most potent on a mass basis [44]. Poten-
tially, such cytotoxicity could influence the silica-induced
IL-1β responses in our mechanistic studies performed at
higher concentrations, in which different inhibitors were
used. At the early time points (6 h) used to assess the IL-
1β responses, however, the particles induced little toxicity
as assessed by LDH-release. In comparison the IL-1β re-
lease was much larger, thus strongly arguing that the
observed responses are not due to release of pro-IL-1β as
a result of plasma membrane rupture. This is also contra-
dicted by the fact that zYVAD and siRNA against NALP3
inhibit the SiNP-induced IL-1β responses.The main goal in the present study was to investigate
the ability of non-crystalline particles to act via inflam-
masome activation in macrophages. We have also com-
pared the relative potency of the non-crystalline silicas
to crystalline silica (MinUsil 5) with respect to IL-1β re-
lease in the primary rat lung macrophages. When related
to surface area the crystalline silica was more potent
than the non-crystalline silicas (in particular compared
to Si50 and Si500), which could suggest a role of crystal-
linity. However, the findings showing that fumed (non-
crystalline) silica particles induced almost the same re-
sponse as crystalline silica, suggest that other factors/
mechanisms also may contribute. Thus, the overall re-
sponse pattern obtained may be influenced by differential
uptake mechanisms for the different silica particles in
the lung macrophages (as previously discussed), but also
to other differences in particle surface reactivity than
caused by crystallinity. Notably, studies with different
quartz particles (nanoscale- and fine quartz) by Warheit
and coworkers [30] indicate that the toxicity of different
particles is more dependent upon particle surface activity
effects than particle size and surface area.
Based on these studies it would be interesting to ex-
plore any possible acute inflammatory effects of non-
crystalline silica particles, in particular for relevant con-
centrations of nano-sized particles in LPS-primed ani-
mals. Any possible implications for possible long-term
effects are not likely as no or minor effects from long-
term industrial use of non-crystalline (amorphous) sil-
ica particles have been reported. This is probably due to
the reduced retention time of the non-crystalline silica
particles in the lung tissue compared to quartz.
Conclusions
In conclusion, different non-crystalline silica particles
from nano- to submicro-metre size ranges induced IL-1β
release from LPS-primed RAW264.7 macrophages and
primary rat lung macrophages. In the primary rat lung
macrophages the silica particle-induced IL-1β responses
occurred at low concentrations, being more sensitive as
a model system, than the RAW264.7 macrophage cell
line. In the lung macrophages crystalline silica (MinUsil
5) was more potent in inducing IL-1β release than the
non-crystalline silica particles, but much less versus
fumed silica particles than versus Si50 and Si500, when
adjusted to surface area. The differential response pat-
terns obtained suggest that silica-induced IL-1β
responses not only depend on the particle surface area,
but on factors and/or mechanisms such as particle re-
activity or particle uptake. The studies in RAW264.7
macrophages showed that silica-induced IL-1β responses
occurred via mechanisms involving particle uptake,
phagosomal destabilization and NALP3 inflammasome
activation. These findings may indicate that bacterial
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Two different mono-disperse non-crystalline (amorph-
ous) silica particles (provided by Kisker Biotech GmbH
& Co, Steinfurt; Germany) with a nominal size of
50 nm (Si50) and 500 nm (Si500) were used. In
addition, two types of poly-disperse, non-crystalline sil-
ica particles were included in this study; fumed silica
(Aerosil 200, Degussa Evonik, Germany) and fused sil-
ica (Suprasil, Heraeus, Germany). MinUsil α-quartz
particles (crystalline silica, MinU-sil 5 from U.S. Silica
Co., Berkeley Springs, WV, US, were also used. The
Si50 and Si500 particles were prepared from an analyt-
ically pure silane precursor via a sol–gel process and
supplied in de-ionized, sterile-filtered water. This
method is known to result in 100% pure amorphous
silica particles. Both fumed silica and fused silica are
prepared from chemically pure chlorosilane precursors
via a pyrogenic process. Fumed silica is collected as
fluffy white powder with a primary particle size of 5–
20 nm, whereas fused silica is delivered in the form of
massive glass rods. The glass rods were crushed and
milled in a swing mill in order to produce sufficiently
small particles of angular morphology. The amorphous
character was confirmed by X-ray diffraction (AXS D8
Advance, LynxEye silicon strip detector). No traces
#of crystalline silica polymorphs were detected. For
#the fused silica a fraction with the smallest particles
obtained after wet sedimentation was used for determin-
ation of size by dynamic light scattering (DLS), ζ-potential,
and in assessing cellular responses.
Stock solutions were prepared in sterile water (final
concentration 2 mg/ml) with bovine serum albumin
(BSA, final concentration 1.5%), and phosphate-
buffered saline (PBS, final dilution 1x) added after
sonication, as according to Bihary et al. [45]. The non-
crystalline silica particles were analyzed for their morph-
ology/dimension/surface charge and area. The morph-
ology of the non-crystalline silica particles was assessed
by transmission electron microscopy (TEM), using a
JEOL JEM 1220 (mono-disperse silicas) and a Philips CM
30 (fumed and fused silicas). The specific surface areas
of the mono-disperse particles were determined by the
single-point Brunauer, Emmet and Teller (BET) pro-
cedure on a customized apparatus developed according
to literature specification (J.M Thomas; W.J.Thomas,
1997) after a slow evaporation at room temperature of
water from the particle suspensions. The BET surface
areas of fumed and fused silica were determined with aMicromeritics Tristar instrument. The hydrodynamic
diameters of the silica particles were determined in
water and in culture media with 10% fetal calf serum
(FCS) by DLS (Malvern Instruments LTD, UK), instantly
and 2 h after dispersion of the particles in the medium.
The ζ-potentials of the silica particles were determined
in water, using a 100 μg/ml final concentration in a
nano-sizer (Malvern instruments, UK).
Cell cultures
The mouse macrophage RAW264.7 cell line was pur-
chased from American Type Tissue Culture Collection
(ATCC, Rockville, MD) and maintained according to
ATCC protocols. Briefly, RAW264.7 cells were cultured in
DMEM with 10% FCS, penicillin-streptomycin and
2 mmol/L L-glutamine (Gibco BRL; Paisley, Scotland, UK)
in 12-well plates (Corning, Lowell, MA, USA), with a
density of 3x105 cells/well, one day prior to exposure, The
rat primary lung macrophages were isolated and cultured
according to a procedure previously described [46]. Briefly,
the macrophages obtained by lung lavage of male rats
(WKY/NHsd, purchased from Harlan, UK), were sus-
pended and cultured in RPMI-medium, with antibiotics
and 5% fetal bovine serum (FBS). Non-attached cells were
removed after 1 h in culture, and fresh RPMI-medium
with FBS was added to the attached cells. The purity of the
macrophages exceeded 90%. Both the RAW264.7 macro-
phages and the primary rat lung cells were pre-treated
with or without lipopolysaccharide (LPS, 25 ng/ml, Sigma-
Aldrich Chemical Company, St Louis, MO, USA) for 3 h,
before exposure to increasing concentrations of the re-
spective particles for 6 h.
In some experiments, an inhibitor of actin assembly
(cytochalasin D, 10 μM Sigma-Aldrich Chemical Com-
pany, St Louis, MO, USA), an inhibitor of caspase-1 ac-
tivity (zYVAD-fmk, 10 μM, EMD Chemicals Inc,
Gibbstown, USA), an inhibitor of vacuolar H+-ATPase
(bafilomycin A1, 250 nM, Calbiochem, Merck KGaA,
Darmstadt, Germany) and an inhibitor of cathepsin B
(Ca-074ME, 50 μM, Sigma-Aldrich Chemical Company,
St Louis, MO, USA) were added to the cells 30 min prior
to silica particle exposure. RAW264.7 macrophages have
previously been reported not to have any NALP3-
inflammasome response, due to a lack of ASC [47]. Here,
however, we observed solid expression of ASC in the
RAW264.7 macrophages used, as measured at the
mRNA-level (data not shown); and similar IL-1 β
responses were observed in LPS-primed J774A.1 macro-
phages, a cell line known to be sensitive with respect to
inflammasome activation [47] (data not shown).
Transfection by siRNA
Pre-designed siRNA probes against NALP3 (siRNA ID:
s103711), and a certified non-silencing control (SilencerW
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tems, Life Technologies Corporation, CA USA. RAW264.7
macrophages were plated in 12-well plates as described
above and transfected using HiPerfect reagent (Qiagen,
GmbH, Hilden, Germany) and 5 nM siRNA. The transfec-
tion reagent and the siRNA probes were mixed by vortex-
ing in OptiMEM (Invitrogen, Life Technologies Ltd, UK)
and incubated for 10 min in room temperature before the
complex was added drop-wise into the cells suspension.
Cells were then incubated for 48 h with transfection com-
plexes in normal medium, washed and incubated for add-
itional 48 h in medium only. The cells were thereafter
exposed to LPS (25 ng/ml) and silica particles (200 μg/ml)
for up to 9 h before harvesting and subsequent RT-PCR
analyses of the silencing.Cell viability
The toxicity of different silica particles and siRNA trans-
fection was assessed investigating cell membrane in-
tegrity using a lactate dehydrogenase (LDH) leakage
assays (“LDH detection kit”, Roche Applied Biosystems,
Penzberg, Germany).Enzyme immunoassays (EIA)
Cell culture media were collected and centrifuged at
300 x g to remove cell debris and at 8000 x g to remove
suspended silica particles. The final supernatants were
stored at −70°C until cytokine analysis. The amount of
IL-1β in cell medium was measured by ELISA (R&D sys-
tems, Minneapolis MN, USA) according to the manufac-
turers’ guideline. An increase in color intensity was
quantified by a plate reader (TECAN Sunrise, Phoenix
Research Products, Hayward, CA, USA) equipped with a
dedicated software (Magellan V I.10).Real time quantitative RT-PCR
Quantification of mRNA was performed using ABI Prism
Fast Real time PCR System (Applied Biosystems, Foster
City, CA). Primers for NALP3 (forward primer: 5’-
TCGACCCTTGGACCAGGTTCAGT -3’, reverse primer:
5’- CATGCCCGGGTCTCCCAGAGT -3’), β-actin (for-
ward primer: 5’-GCAGCTCCTTCGTTGCCGGT-3’, re-
verse primer: 5’-TACAGCCCGGGGAGCATCGT-3’) and
for ASC (forward primer: 5’-TGGCTGAGCAGCTGCAA
ACGA-3’, reverse primer: 5’-TGCTGGTCCACAAAGT
GTCCTGTT-3’), were designed using the NCBI primer-
BLAST software (http://www.ncbi.nlm.nih.gov/tools/pri-
mer-blast/). One pair of ASC primers was adapted from
Pelegrin [47]. Cell harvesting and RNA preparation were
performed according to the “Cells-to-Ct” Kit protocol
(Applied Biosystems, Life Technologies Corporation, CA
USA) and qPCR was performed by using Master Mix
for Power SyBr Green and 300 nM primers. Geneexpression of the house-keeping gene β-actin was used for
normalization.
Western blotting
The pro-IL-1β levels were also quantified by Western
analysis. After exposure to particles, the cell-culture
dishes were washed twice with PBS, before the dishes
were stored at - 70°C until further processing. Frozen cell
culture dishes were put on ice and 200 μl lysis buffer
was added. After 5–10 min the cells were scraped and
sonicated prior to protein determination, using the
BioRad DC Protein Assay (BioRAD Life Science, CA,
USA). The samples (70 μg protein/well) were run on
SDS-PAGE (15%) gels before transferring onto nitrocel-
lulose membranes (NEN, Life Science, Boston, MA,
USA). To ensure that the protein levels of each well were
equal, Ponceau-staining was used. After blocking, mem-
branes were incubated with rat antibody against IL-1β
(Santa Cruz, CA, USA), prior to exposure with species-
specific horseradish peroxidase-coupled secondary anti-
bodies (Cell signaling, Beverly, MA, USA). The blots
were developed using the Super-Signal West Dura che-
moluminiscience system (Pierce, Perbio Science, Sweden)
according to the manufacturers’ instructions. Finally, the
membranes were stripped by incubations for 15 min at
room temperature with mild antibody stripping solution,
and re-probed with mouse anti-β-actin (Sigma-Aldrich;
St. Louis; MO, USA).
Statistical analysis
Data are presented as mean ± standard deviation (SD).
Probability values were considered significant at p <0.05.
The data were analysed by the nonparametric one-way
ANOVA analysis; Kruskal-Wallis test. Dunn’s Multiple
Comparison test was used as a post-test, when compar-
ing samples inside the dataset.
Additional file
Additional file 1: Figure S1. Hydrodynamic sizes of Si50 and Si500
particles in water and in culture medium. Figure S2. Hydrodynamic sizes
of fumed and fused silica particles in water and in culture medium.
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